- Home
- OABI vs NVX Comparison
OABI vs NVX Comparison
Compare OABI & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- NVX
- Stock Information
- Founded
- OABI 2012
- NVX 2012
- Country
- OABI United States
- NVX Australia
- Employees
- OABI N/A
- NVX N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- NVX Industrial Machinery/Components
- Sector
- OABI Health Care
- NVX Miscellaneous
- Exchange
- OABI Nasdaq
- NVX Nasdaq
- Market Cap
- OABI 198.2M
- NVX 176.8M
- IPO Year
- OABI N/A
- NVX N/A
- Fundamental
- Price
- OABI $2.18
- NVX $1.07
- Analyst Decision
- OABI Strong Buy
- NVX
- Analyst Count
- OABI 3
- NVX 0
- Target Price
- OABI $7.00
- NVX N/A
- AVG Volume (30 Days)
- OABI 854.4K
- NVX 57.9K
- Earning Date
- OABI 08-07-2025
- NVX 01-01-0001
- Dividend Yield
- OABI N/A
- NVX N/A
- EPS Growth
- OABI N/A
- NVX N/A
- EPS
- OABI N/A
- NVX N/A
- Revenue
- OABI $26,744,000.00
- NVX $5,854,424.00
- Revenue This Year
- OABI N/A
- NVX $66.66
- Revenue Next Year
- OABI $45.65
- NVX $2,366.64
- P/E Ratio
- OABI N/A
- NVX N/A
- Revenue Growth
- OABI 27.07
- NVX N/A
- 52 Week Low
- OABI $1.22
- NVX $0.81
- 52 Week High
- OABI $4.96
- NVX $2.73
- Technical
- Relative Strength Index (RSI)
- OABI 72.48
- NVX 45.41
- Support Level
- OABI $1.79
- NVX $1.06
- Resistance Level
- OABI $1.73
- NVX $1.21
- Average True Range (ATR)
- OABI 0.11
- NVX 0.06
- MACD
- OABI 0.04
- NVX 0.01
- Stochastic Oscillator
- OABI 93.97
- NVX 36.36
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.